4-119248751-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001371395.1(USP53):c.241A>T(p.Ile81Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0121 in 1,611,292 control chromosomes in the GnomAD database, including 166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0090 ( 6 hom., cov: 31)
Exomes 𝑓: 0.012 ( 160 hom. )
Consequence
USP53
NM_001371395.1 missense
NM_001371395.1 missense
Scores
2
5
11
Clinical Significance
Conservation
PhyloP100: 6.03
Genes affected
USP53 (HGNC:29255): (ubiquitin specific peptidase 53) Predicted to enable thiol-dependent deubiquitinase. Predicted to be involved in response to auditory stimulus and sensory perception of sound. Predicted to act upstream of or within action potential and neuron apoptotic process. Predicted to be located in bicellular tight junction. Predicted to be active in cell-cell junction. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014961064).
BP6
Variant 4-119248751-A-T is Benign according to our data. Variant chr4-119248751-A-T is described in ClinVar as [Benign]. Clinvar id is 773456.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00899 (1369/152326) while in subpopulation NFE AF= 0.014 (950/68034). AF 95% confidence interval is 0.0132. There are 6 homozygotes in gnomad4. There are 625 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP53 | NM_001371395.1 | c.241A>T | p.Ile81Leu | missense_variant | 7/19 | ENST00000692078.1 | NP_001358324.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP53 | ENST00000692078.1 | c.241A>T | p.Ile81Leu | missense_variant | 7/19 | NM_001371395.1 | ENSP00000509606 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00899 AC: 1369AN: 152208Hom.: 6 Cov.: 31
GnomAD3 genomes
AF:
AC:
1369
AN:
152208
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00936 AC: 2307AN: 246434Hom.: 21 AF XY: 0.00985 AC XY: 1316AN XY: 133550
GnomAD3 exomes
AF:
AC:
2307
AN:
246434
Hom.:
AF XY:
AC XY:
1316
AN XY:
133550
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0124 AC: 18056AN: 1458966Hom.: 160 Cov.: 30 AF XY: 0.0121 AC XY: 8810AN XY: 725624
GnomAD4 exome
AF:
AC:
18056
AN:
1458966
Hom.:
Cov.:
30
AF XY:
AC XY:
8810
AN XY:
725624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00899 AC: 1369AN: 152326Hom.: 6 Cov.: 31 AF XY: 0.00839 AC XY: 625AN XY: 74480
GnomAD4 genome
AF:
AC:
1369
AN:
152326
Hom.:
Cov.:
31
AF XY:
AC XY:
625
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
45
ALSPAC
AF:
AC:
38
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
113
ExAC
AF:
AC:
1185
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | USP53: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Pathogenic
D;D
Polyphen
P;P
Vest4
MutPred
Gain of ubiquitination at K79 (P = 0.1215);Gain of ubiquitination at K79 (P = 0.1215);
MVP
MPC
0.16
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at